Whereas FcγRIIb was essential for prevention of ITP and arthritis by sIgG, it was not important for protection against fatal HSE by low dose IVIG (i.e., lacking sIgG). The gene discussed is FCGR2B; the disease is autoimmune thrombocytopenic purpura.